This website is for Irish healthcare professionals. This website contains promotional material.

Reporting adverse events
A
A
Prescribing information for:

Ferinject 
(ferric carboxymaltose)

Venofer 
(iron sucrose)

Find out more about how treatment of iron deficiency with Ferinject
could support your treatment goals for patients with heart failure
and chronic kidney disease

 

WEBINARS AND EVENTS

FERINJECT®
(ferric carboxymaltose)

Ferinject IN patients
with ND-CKD

Discover how treating iron deficiency with Ferinject can help your patients with non-dialysis chronic kidney disease, as well as the key clinical data supporting its efficacy and tolerability profile

Read More

FERINJECT IN PATIENTS WITH
HEART FAILURE

Explore the results of AFFIRM-AHF, a clinical trial that supports treatment of iron deficiency with Ferinject to improve outcomes in patients with heart failure

Read More

Oral or IV iron

Learn more about how these two treatments compare when treating patients for iron deficiency

Read More

2023 FOCUSED UPDATE
OF THE ESC 2021 HF
GUIDELINES

Find out more about treating iron deficiency according to the 2023 focused update to the ESC 2021 heart failure guidelines

Read More

CKD, Chronic Kidney Disease; ESC, European Society of Cardiology; HF, heart failure; IV, intravenous; ND-CKD, non-dialysis chronic kidney disease.

More Resources

Webinars and events

Resources

You are now heading to a third-party website that we do
not operate. We are not responsible for the content of the
third-party website. You are advised to review its privacy policy
as it may differ from ours.

 

Are you sure you want to leave?

Confirm

Cancel

Report adverse events in Ireland:

Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie.

Adverse events should also be reported to Vifor Pharma UK Ltd. Tel: (+44) 01276 853633 or email: medicalinfo_UK@viforpharma.com.